Cargando…
Mild encephalopathy with reversible splenium lesion (MERS) in a patient with COVID-19
Neurological complications of coronavirus 2019 (COVID-19) are common, and novel manifestations are increasingly being recognized. Mild encephalopathy with reversible splenium lesion (MERS) is a syndrome that has been associated with viral infections, but not previously with COVID-19. In this report,...
Autores principales: | Kakadia, Bhavika, Ahmed, Jaffer, Siegal, Todd, Jovin, Tudor G., Thon, Jesse M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340073/ https://www.ncbi.nlm.nih.gov/pubmed/33070911 http://dx.doi.org/10.1016/j.jocn.2020.07.009 |
Ejemplares similares
-
Mild Encephalopathy with Reversible Lesion in the Splenium of the Corpus Callosum and Bilateral Frontal White Matter
por: Cho, Jeong-Seon, et al.
Publicado: (2007) -
Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021) -
Mild Encephalopathy With Partial Reversible Splenium Lesion Associated With SARS-CoV-2 Infection
por: Reyes, Cleo Zarina A, et al.
Publicado: (2023) -
Mild Encephalopathy with Reversible Lesions in the Splenium of Corpus Callosum and Bilateral Cerebral Deep White Matter in Identical Twins
por: Tahara, Junko, et al.
Publicado: (2016) -
Reversible lesion in the splenium of the corpus callosum
por: Tetsuka, Syuichi
Publicado: (2019)